Moneycontrol PRO
Loans
Loans
HomeNewsBusinessAurobindo Q1 PAT may dip 26.1% YoY to Rs 568.8 cr: ICICI Direct

Aurobindo Q1 PAT may dip 26.1% YoY to Rs 568.8 cr: ICICI Direct

Net Sales are expected to increase by 5.1 percent Y-o-Y (up 3.2 percent Q-o-Q) to Rs 5,994.3 crore, according to ICICI Direct.

July 13, 2022 / 19:10 IST
SMS Lifesciences India

SMS Lifesciences India

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its first quarter (April-June’ 22) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Aurobindo to report net profit at Rs 568.8 crore down 26.1% year-on-year (down 22.6% quarter-on-quarter).

Net Sales are expected to increase by 5.1 percent Y-o-Y (up 3.2 percent Q-o-Q) to Rs 5,994.3 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 14.6 percent Y-o-Y (up 6 percent Q-o-Q) to Rs 1,032.6 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

ICICI_Pharma

Broker Research
first published: Jul 13, 2022 07:10 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347